SOURCE: BIOLASE Technology, Inc.

September 18, 2008 06:00 ET

BIOLASE Receives Two New Patents Covering Consumable Laser Tips and Related Technologies

IRVINE, CA--(Marketwire - September 18, 2008) - BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, today announced that it has been granted two new U.S. patents related to technologies that are central to the use of consumable laser tips to deliver therapy to patients across a range of dental and other medical specialties.

Patent No. 7,421,186, entitled Modified-Output Fiber Tips, covers laser tips that can be configured to direct energy in multiple directions including to the sides, away from the handpiece. This patent relates not only to a diverse set of dental applications, but also to certain non-dental applications that the Company may choose to market through strategic partners. The patent contains 33 claims, of which six are independent.

Patent No. 7,424,199, entitled Fiber Tip Fluid Output Device, covers the situating of a fiber tip within an electromagnetic cutting instrument as well as directing water particles over the delivery end of that fiber tip. This patent is central to the Company's current and future tip technologies, including the disposable tips that are central to the Company's strategy of expanding recurring revenues while delivering clinically superior devices to its customers and their patients. The patent contains 46 claims, of which 10 are independent.

BIOLASE CEO Jake St. Philip said that these new patents come at a key time, while the Company is increasing focus on its consumables business and continuing to expand overseas. "These patents not only bolster our overall formidable patent portfolio, but also arm us with powerful intellectual property protection as we grow our consumables business and generate new products at home and overseas," St. Philip said.

BIOLASE has currently been granted or applied for 325 U.S. and foreign patents.

About BIOLASE Technology, Inc.

BIOLASE Technology, Inc. (, the world's leading dental laser company, develops, manufactures and markets lasers and related products that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Contact Information

  • For further information, contact:
    David M. Mulder
    Chief Financial Officer
    BIOLASE Technology, Inc.

    Jill Bertotti
    Allen & Caron